CEP
CLVS

Chicago Equity Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Chicago Equity Partners’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-23,810
Closed -$1.96M – 852
2017
Q3 		$1.96M Sell
23,810
-18,550
-44% -$1.47M 0.06% 375
2017
Q2 		$3.97M Buy
42,360
+22,840
+117% +$1.4M 0.11% 231
2017
Q1 		$1.24M Buy
19,520
+400
+2% +$24.3K 0.04% 423
2016
Q4 		$849K Buy
+19,120
New +$673K 0.02% 494

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Chicago Equity Partners's CLVS Position: Q4 2017 in Review

Chicago Equity Partners sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 23,810 shares — an estimated $1.96M sold.

Chicago Equity Partners first reported a position in CLVS in Q4 2016 and held it in 4 quarters. The position peaked at $3.97M in Q2 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • Chicago Equity Partners reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
  • Chicago Equity Partners sold 23,810 Clovis Oncology, Inc. shares in Q4 2017, an estimated $1.96M.
  • Chicago Equity Partners first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 4 quarters.
  • Chicago Equity Partners's Clovis Oncology, Inc. position peaked at $3.97M in Q2 2017.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Chicago Equity Partners's 13F filing for Q4 2017, filed 31 Jan 2018.